These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7392529

  • 1. [Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)].
    Bulla M, Delling G, Benz-Bohm G, Stock GJ, Sánchez de Reutter A, Ziegler R, Lühmann H, Severin M, Kalbitzer E, Manegold C.
    Klin Wochenschr; 1980 May 16; 58(10):511-9. PubMed ID: 7392529
    [Abstract] [Full Text] [Related]

  • 2. [Influence of vitamin D therapy on renal osteodystrophy in children (author's transl)].
    Bulla M, Stock GJ, Delling G, Hofmann H, Offermann G.
    Klin Wochenschr; 1980 Mar 03; 58(5):237-47. PubMed ID: 6249957
    [Abstract] [Full Text] [Related]

  • 3. Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.
    Velentzas C, Oreopoulos DG, Pierratos A, Meema HE, Rabinovich S, Meindok H, Husdan H, Murray TM, Ogilvie R, Katirtzoglou A.
    Can Med Assoc J; 1981 Mar 01; 124(5):577-83. PubMed ID: 6894103
    [Abstract] [Full Text] [Related]

  • 4. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL.
    Ann Intern Med; 1981 Mar 01; 94(3):404-5. PubMed ID: 6894359
    [No Abstract] [Full Text] [Related]

  • 5. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
    Massry SG, Goldstein DA, Malluche HH.
    Kidney Int; 1980 Oct 01; 18(4):409-18. PubMed ID: 7014981
    [No Abstract] [Full Text] [Related]

  • 6. Long-term therapy of uremic osteodystrophy in adults with calcitriol.
    Moorthy AV, Harrington AR, Mazess RB, Simpson DP.
    Clin Nephrol; 1981 Aug 01; 16(2):93-100. PubMed ID: 6894893
    [Abstract] [Full Text] [Related]

  • 7. 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
    Pierides AM, Ellis HA, Dellagrammatikas H, Scott JE, Norman AW.
    Arch Dis Child; 1977 Jun 01; 52(6):464-72. PubMed ID: 879832
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N, Catto GR, Edward N, Fraser RA, O'Riordan JL, Papapoulos SE, Adami S.
    Proc Eur Dial Transplant Assoc; 1980 Jun 01; 17():543-7. PubMed ID: 6972529
    [Abstract] [Full Text] [Related]

  • 9. 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.
    Brickman AS, Sherrard DJ, Jowsey J, Singer FR, Baylink DJ, Maloney N, Massry SG, Norman AW, Coburn JW.
    Arch Intern Med; 1974 Nov 01; 134(5):883-8. PubMed ID: 4613310
    [No Abstract] [Full Text] [Related]

  • 10. 1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy.
    Váry L.
    Int Urol Nephrol; 1980 Nov 01; 12(3):241-7. PubMed ID: 7251289
    [Abstract] [Full Text] [Related]

  • 11. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
    Pierides AM, Skillen AW, Ellis HA.
    J Lab Clin Med; 1979 Jun 01; 93(6):899-909. PubMed ID: 438610
    [Abstract] [Full Text] [Related]

  • 12. Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations.
    Baker LR, Muir JW, Cattell WR, Tucker KA, Sharman VL, Goodwin FJ, Marsh FP, Hately W, Morgan AG, de Saintonge DM.
    Contrib Nephrol; 1980 Jun 01; 18():147-51. PubMed ID: 7353373
    [Abstract] [Full Text] [Related]

  • 13. [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy].
    Reutter FW, Sieber R, Olah AJ, Dambacher MA.
    Schweiz Med Wochenschr; 1979 Dec 08; 109(47):1880-3. PubMed ID: 531567
    [Abstract] [Full Text] [Related]

  • 14. Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
    Coburn JW, Brickman AS.
    Adv Exp Med Biol; 1978 Dec 08; 103():473-86. PubMed ID: 362852
    [No Abstract] [Full Text] [Related]

  • 15. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
    Muirhead N, Adami S, Sandler LM, Fraser RA, Catto GR, Edward N, O'Riordan JL.
    Q J Med; 1982 Dec 08; 51(204):427-44. PubMed ID: 6760236
    [Abstract] [Full Text] [Related]

  • 16. Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.
    Chesney RW, Hamstra A, Jax DK, Mazess RB, DeLuca HF.
    Contrib Nephrol; 1980 Dec 08; 18():55-71. PubMed ID: 7353380
    [No Abstract] [Full Text] [Related]

  • 17. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM, Davin JC, Lambrechts L, Heynen G.
    Ann Endocrinol (Paris); 1979 Dec 08; 40(2):161-2. PubMed ID: 475307
    [Abstract] [Full Text] [Related]

  • 18. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
    Maxwell DR, Benjamin DM, Donahay SL, Allen MK, Hamburger RJ, Luft FC, Kleit SA.
    Proc Clin Dial Transplant Forum; 1977 Dec 08; 7():166-9. PubMed ID: 210446
    [No Abstract] [Full Text] [Related]

  • 19. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P, Zingraff J, Gueris J, Jungers P, Marie P, Pechet M, Rasmussen H.
    Am J Med; 1978 Jan 08; 64(1):101-7. PubMed ID: 623125
    [Abstract] [Full Text] [Related]

  • 20. Calcitriol in dialysis patients.
    Maxwell DR, Benjamin DM, Donahay SL, Allen MK, Hamburger RJ, Luft FC.
    Clin Pharmacol Ther; 1978 May 08; 23(5):515-9. PubMed ID: 205382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.